GlassScriptPhysician profile
Shelby Parrish
NPI 1295227064
$2,698.43
in general payments reported to CMS, 2019-2025
25 companies · $608 in 2025
The $608 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $683 · 2023: $403 · 2024: $468 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.12 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $283.01 | 2021-2025 | Winlevi |
| Abbvie INC. | $270.21 | 2022-2025 | |
| Incyte Corporation | $236.84 | 2021-2025 | Opzelura |
| Genzyme Corporation | $219.44 | 2021-2025 | |
| Amgen INC. | $198.57 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $159.44 | 2021-2024 | Taltz, Olumiant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $144.03 | 2021-2025 | Jublia, Cabtreo, Arazlo |
| Janssen Biotech, INC. | $138.63 | 2022-2024 | Tremfya |
| Journey Medical Corporation | $133.50 | 2021-2023 | |
| Ucb, INC. | $124.42 | 2021-2022 | |
| Galderma Laboratories, L.P. | $119.49 | 2021-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $94.12 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $89.50 | 2021-2025 | Dupixent |
| Mayne Pharma Commercial LLC | $75.24 | 2021-2023 | |
| Leo Pharma INC. | $68.71 | 2021-2023 | Adbry |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $66.66 | 2022-2025 | |
| Almirall LLC | $55.30 | 2022-2023 | Klisyri |
| Botanix Sb INC | $51.50 | 2025 | Sofdra |
| Janssen Scientific Affairs, LLC | $34.99 | 2021 | |
| Pfizer INC. | $28.64 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $28.32 | 2022-2025 | Sotyktu |
| Dermavant Sciences, INC. | $27.74 | 2023-2024 | Vtama |
| Convatec INC. | $17.59 | 2024 | |
| Lnhc, INC | $16.68 | 2025 | Zelsuvmi |
| Organogenesis INC. | $15.86 | 2025 | Simplimax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.